These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 38179677)
1. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [ Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677 [TBL] [Abstract][Full Text] [Related]
2. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy. Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827 [TBL] [Abstract][Full Text] [Related]
3. Translational imaging of the fibroblast activation protein (FAP) using the new ligand [ Backhaus P; Gierse F; Burg MC; Büther F; Asmus I; Dorten P; Cufe J; Roll W; Neri D; Cazzamalli S; Millul J; Mock J; Galbiati A; Zana A; Schäfers KP; Hermann S; Weckesser M; Tio J; Wagner S; Breyholz HJ; Schäfers M Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1822-1832. PubMed ID: 34957527 [TBL] [Abstract][Full Text] [Related]
4. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy. Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528 [TBL] [Abstract][Full Text] [Related]
6. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy. Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362 [TBL] [Abstract][Full Text] [Related]
8. A comparison of [ Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909 [TBL] [Abstract][Full Text] [Related]
9. Clinical translation of a novel FAPI dimer [ Tan Y; Li J; Zhao T; Zhou M; Liu K; Xiang S; Tang Y; Jakobsson V; Xu P; Chen X; Zhang J Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2761-2773. PubMed ID: 38561515 [TBL] [Abstract][Full Text] [Related]
10. [ Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920 [TBL] [Abstract][Full Text] [Related]
11. Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy. Xu M; Zhang P; Ding J; Chen J; Huo L; Liu Z J Nucl Med; 2022 Jun; 63(6):952-958. PubMed ID: 34593598 [TBL] [Abstract][Full Text] [Related]
12. [ Shang Y; Zhang G; Yao X; Lai C; Wang F; Zeng B; Liu E; Yuan H; Cheng Z; Jiang L Mol Imaging Biol; 2024 Aug; 26(4):729-737. PubMed ID: 38987449 [TBL] [Abstract][Full Text] [Related]
13. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571 [TBL] [Abstract][Full Text] [Related]
14. Non-invasive visualization of liver fibrosis with [ Song Y; Qin C; Chen Y; Ruan W; Gai Y; Song W; Gao Y; Hu W; Qiao P; Song X; Lv X; Zheng D; Chu H; Jiang D; Yang L; Lan X Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3572-3584. PubMed ID: 38850311 [TBL] [Abstract][Full Text] [Related]
15. Design, Preclinical Evaluation, and Clinical Translation of Zhao L; Pang Y; Fang J; Chen J; Zhou Y; Sun L; Wu H; Guo Z; Lin Q; Chen H J Nucl Med; 2024 Mar; 65(3):394-401. PubMed ID: 38176714 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma. Lai C; Cao R; Li R; He C; Wang X; Shi H; Qu C; Qian K; Song S; Chen WH; Cheng Z Mol Pharm; 2023 Aug; 20(8):4120-4128. PubMed ID: 37487027 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [ Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of preoperative [ Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [ Zang J; Wen X; Lin R; Zeng X; Wang C; Shi M; Zeng X; Zhang J; Wu X; Zhang X; Miao W; Xu P; Guo Z; Zhang J; Chen X Theranostics; 2022; 12(16):7180-7190. PubMed ID: 36276644 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of [ Unterrainer LM; Lindner S; Eismann L; Casuscelli J; Gildehaus FJ; Bui VN; Albert NL; Holzgreve A; Beyer L; Todica A; Brendel M; Cyran CC; Karl A; Stief CG; Ledderose ST; Unterrainer M; Bartenstein P; Wenter V; Kretschmer A Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3571-3580. PubMed ID: 35325283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]